Pharmaceuticals. 2024 Aug 5. doi: 10.3390/ph17081033.
B.Dhaini, P.Arnoux, J.Daouk, et al.
Archives Publications 2024
GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution
Clinical and Translational Radiation Oncology. 2024 Jul 31. doi: 10.1016/j.ctro.2024.100833.
J.Biau, X.Durando, F.Boux, et al.
Quantifying gadolinium-based nanoparticle uptake distributions in brain metastases via magnetic resonance imaging
Scientific Reports, 2024 May 25. Article number: 11959 (2024).
S.Bennett, C.Verry, E.Kaza, et al.
Nanotechnology-based delivery systems to overcome drug resistance in cancer
Immunologie. 2024 Jan 15. doi: 10.1101/2024.01.12.575217.
Z.Muradova, D.Tannous, A.Mostefa-Kara, et al.
Gadolinium-based nanoparticles AGuIX and their combination with ionizing radiation trigger AMPK-dependent proinflammatory reprogramming of tumor-associated macrophages
Immunologie. 2024 Jan 15. doi: 10.1101/2024.01.12.575217.
Z.Muradova, D.Tannous, A.Mostefa-Kara, et al.
AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors
Nanoscale. 2024 Feb 1;16(5):2347-2360. doi: 10.1039/d3nr04777f.
L.Carmès, G.Bort, F.Lux, et al.